Molecular conjugates containing cell membrane-blending agents

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 15 to 23 amino acid residues in defined sequence

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530322, 530324, 530345, 530377, 5303911, 5303917, 5303919, 530408, 530409, 530410, 536 27, 536 28, 536 29, C07K 710, C07K 1702

Patent

active

051497824

ABSTRACT:
Molecular conjugates which facilitate the attachment of macromolecular drugs onto cellular surfaces and their entry into cells are described. The molecular conjugates comprise a macromolecular drug linked to an "inactivated" membrane blending agent which inserts into the cellular plasma membrane. The membrane blending agent is inactivated by cleavable linkage to a blocking agent which, until released from the conjugate under appropriate conditions, blocks and ability of the membrane blending agent to insert into the cellular membrane. Upon release of the blocking agent, the membrane blending agent is "activated" and the conjugate can be inserted into a cellular plasma membrane. The membrane blending agents can be peptides such as fusogenic or ion channel forming peptides or long chain fatty acids. The blocking agents can be bulky or charged moieties which mask and prevent insertion of the membrane blending agent.

REFERENCES:
patent: 4362716 (1982-12-01), Bouchandon et al.
patent: 4664911 (1987-05-01), Uhr et al.
patent: 4731324 (1988-03-01), Huang et al.
patent: 4859769 (1989-08-01), Karlsson et al.
patent: 4892827 (1990-01-01), Pastan et al.
patent: 4894443 (1990-01-01), Greenfield et al.
Byers et al., Abstract No. 942.
Splitler et al., (1987) Cancer Research 47:1717-1723.
Pierce Catalog p. A-10 "Trault's Regent".
Hwang et al., (1987) Cell 48:129-136.
Marsh J. W. et al., "A Flexible Peptide Spacer Increases the efficacy of Holoricin Anti-T cell Immunotoxins" J. Immunol. 140:3674-3678 (1988).
Griffin, T. W. et al., "Antitumor Activity of Intraperitoneal Immunotoxins in a Nude Mouse Model of Human Malignant Mesothelioma" Cancer Research 49: 4266-4270 (1987).
Neville, D. M. Jr., et al., "Enhancement of Immunotoxin Efficacy by Acid-Cleavable Cross-Linking. Agents Utilizing Diptheria Toxin and Toxin Mutants" J. Biological Chemistry 264:14653-14661 (1989).
Olsnes S., et al., "Immunotoxins-entry into cells and Mechanisms of action" Immunology Today 10:291-295 (1989).
Chovnick, A., et al., "A Recombinant, Membrane-acting Immunotoxin" Cancer Research 51:465-467 (1991).
May, R. D., et al., "Evaluation of Ricin A Chain-Containing Immunotoxins Directed Against Different Epitopes on the S-chain of Cell Surface-Associated IgD on Murine B Cells" I. Immunology 144:3637-3642 (1990).
Kabanov, A. V., et al., "Fatty Acylation of Proteins for Translocation Across Cell Membranes" Biomedical Science 1:33-36 (1990).
Schmidt, MFG, "Fatty Acylation of Proteins" Biochimica et Biophysica Acta 988:411-426 (1989).
Hu, J. S., et al., "Protein Fatty Acylation: A Novel Mechanism for Association of Proteins with Membranes and its Role in Transmembrane Regulatory" Biofactors 1:219-226 (1988).
Vander Wiele, F. C., et al., "Site-Specific E-NH.sub.2 Monoacylation of Pancreatic Phospholipase A.sub.2, 2, Transformation of Soluble Phospholipase A.sub.z into a Highly Penetrating Membrane-Bound Form" Biochemistry 27:1688-1694 (1988).
Huang, A., et al., "Monoclonal Antibody Covalently Coupled with Fatty Acid" J. Biological Chemistry 255:8015-8015 (1980).
Thorpe P. E., et al., "Improved Antitumor Effects of Immunotoxins Prepared with Deglycosylated Ricin A-Chain and Hindered Disulfide Linkages" Cancer Research 48:6396-6403 (1988).
Diaz, R. E. C., et al., "Activation of Bee Venom Phospholipase A.sub.2 124 Oleoyl Imidazolide produces a thiol- and proteinaseresistant conformation" Biochimica et Biophysica Acta 830:52-58 (1985).
Sandvig, K, et al., "Diphtheria Toxin-induced Channels in Vero Cells Selective for Monovalent Cations". J. Biological Chemistry 263:12352-12359 (1988).
Mozhaev, V. V., et al., "Protein Stabilization via hydrophilization" Eur. J. Biochem 173:147-154 (1988).
Faro-Rivas, J., et al., "Capping and Co-Capping of Membrane Immunoglobulin and Lipid-Conjugated Immunoglobulin Inserted in the Cell Membrane of B Lympocytes" Scand. J. Immunol. 30:435-440 (1989).
Peacock, J. S. et al., "Biological Acting of Antigen Receptors Artifically Incorporated onto B Lymphocytes" J. Immunol. 137:1916-23 (1986).
Grant, S. R., et al., "A Model System for Studies of Specific membrane Interactions" Biochemistry 21:1274-1279 (1982).
Vanderwiele, F. C., et al., "Site-Specific E-NH.sub.2 Monoacylation of Pancreatic Phospholipase A.sub.2 I. Preparation and Properties" Biochemistry 27:1683-1688 (1988).
Brochure by Immunogen, Inc.
Thorpe, P. E. et al. "Blockade of Galactose-Binding Sites of Ricin by its Linkage to Antibody" Eur. J. Biochem. 140 63:71 (1984).
George S. K. et al., "Development of a Universal Membrane Targeting System" Protein Engineering and Production, Bio/technology (1988).
Pellman, D. "An N-Terminal Peptide from p60 spc . . . " Nature 314:374-77 (1985).
George et al., Proc. 1988 Miami Bio/Technology Winter Symposium, IRL press, Washington, D. C., p. 33 Feb. 8-12, 1988.
Pasten et al., Cell, 47:641-648 (1986).
Gallaher et al., Cell, 50:327-328 (1987).
White et al., Quarterly Rev. Biophysics, 16:151-195 (1983).
Gething et al., J. Cell Bio., 102:11-23 (1986).
Guy, Biophysics J., 45:249 (1984).
Finer-Moore and Stroud, Proc. Natl. Acad. Sci., USA, 81:155 (1984).
Greenblatt et al., FEBS Letter, 193:125 (1985).
Lear et al., Science, 240:1177-1181 (1988).
Schlessinger, Ann. Rev. Biochem., 50:193-206 (1981).
Magee et al., Biochem. Biphys. Acta, 798:156-166 (1984).
Streuli and Griffin, Nature, 326:619-622 (1987).
Chow et al., Nature, 327:482-486 (1987).
Pellman et al., Nature, 314:374-377 (1985).
Vitetta et al., Science, 238:1098-1104 (1987).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Molecular conjugates containing cell membrane-blending agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Molecular conjugates containing cell membrane-blending agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Molecular conjugates containing cell membrane-blending agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1069092

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.